Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28926765 | 0.93 | PPARD (0.46) | PPARDTSHRLMNACA12CA1 | |
| SCHEMBL3682968 | 0.88 | PPARD (0.50) | PPARDTSHRTP53TDP1CA12 | |
| SCHEMBL3680110 | 0.84 | PPARD (0.47) | PPARDTSHRTP53TDP1CA12 | |
| SCHEMBL28971492 | 0.82 | PPARD (0.45) | PPARDTSHRTP53TDP1CA12 | |
| SCHEMBL26454327 | 0.82 | PPARD (0.48) | PPARDTSHRTP53TDP1 | |
| SCHEMBL9508475 | 0.81 | LMNA (0.34) | LMNA | |
| SCHEMBL26455500 | 0.81 | PPARD (0.44) | PPARDTSHRTP53TDP1CA12 | |
| SCHEMBL26455196 | 0.81 | PPARD (0.44) | PPARDTSHRTP53TDP1CA12 | |
| SCHEMBL5017294 | 0.78 | PPARD (0.64) | PPARDTSHRTP53TDP1 | |
| SCHEMBL7268189 | 0.78 | PPARD (0.64) | PPARDTSHRTP53TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0985702-B1 | Flame retardant dispersion composition | CONSORTIUM ELEKTROCHEM IND (DE) | 2002-11-27 | — | — | EP | claimed |
| US-6111002-A | Flame-retardant dispersion composition | WACKER-CHEMIE GMBH (DE) | 2000-08-29 | — | — | US | claimed |
| US-20230272014-A1 | COMPOSITION OF NANOPARTICLES AS CARRIER FOR HPV-DERIVED IMMUNOGENIC FRAGMENTS | LIFE SCIENCE INKUBATOR BETRIEBS GMBH & CO. KG (DE) | 2023-08-31 | — | — | US | disclosed |
| US-20230181727-A1 | COMPOSITION OF NANOPARTICLES | LIFE SCIENCE INKUBATOR BETRIEBS GMBH & CO. KG (DE) | 2023-06-15 | — | — | US | disclosed |
| CN-115668570-A | Nonaqueous electrolyte solution and nonaqueous electrolyte battery | 三菱化学株式会社 | 2023-01-31 | — | — | CN | disclosed |
| US-6111002-A | Flame-retardant dispersion composition | WACKER-CHEMIE GMBH (DE) | 2000-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230181727-A1 | COMPOSITION OF NANOPARTICLES | CD47, CD63, HLA-C | PPARD 4296/4885TSHR 4502/4885LMNA 1368/4885 |
| US-20230272014-A1 | COMPOSITION OF NANOPARTICLES AS CARRIER FOR HPV-DERIVED IMMUNOGENIC FRAGMENTS | TP53, TSG101, CD47 | PPARD 4354/4885TSHR 4690/4885LMNA 1751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.